Skip to content
Search

Latest Stories

British Indian doctors probe ethnicity factor in Covid-19 vulnerability

Indian-origin doctors in the UK have initiated an in-depth research into the role of ethnicity in greater susceptibility of BAME communities to develop more critical symptoms of Covid-19.

A report by the UK's Intensive Care National Audit and Research Centre (ICNARC) this week had revealed that the country’s ethnic minority population is more likely to require intensive care admissions, nearly triple the 13 per cent proportion in the UK population as a whole.


"We have a team of researchers on this because it is important to analyse the factors behind these differentiating factors so that communities can put additional preventive measures in place,” said Dr Ramesh Mehta, the president of the British Association of Physicians of Indian Origin (BAPIO), the main representative group for Indian doctors in the UK.

"The reasons behind this trend will not be any one thing but a complex set of factors, be it Vitamin D deficiency, the lack of social distancing measures within a large Indian family household set up or a genetic predisposition. We will know only once we have the relevant data to analyse,” he said.

BAPIO has written to the Chief Medical Officer of England, Professor Chris Whitty, and Medical Director of NHS England Stephen Powis, this week requesting all the official data available on Covid-19 hospital admissions for its research.

"The most recent ICNARC data of UK intensive care unit attendance is some of the first signals of the concern that Covid-19 has a more severe (lethal) phenotype in BAME [Black, Asian and Minority Ethnic] groups, with more than 25 per cent being Black or Asian, and more than a third being non-Caucasian,” notes the letter.

It adds: “We need a better understanding of the issues of BAME mortality in the context of the general population, particularly if it helps us manage sick and vulnerable groups, and so that we can be accurate in our messaging.

"We are therefore asking that the data for COVID cases, and most certainly those who have died as a result of the illness, incorporates ethnicity and profession, as well as the usual demographic data."

The concern around the limited data available so far is also linked to hundreds of Indian-origin retired doctors answering the National Health Service (NHS) call to arms for them to return to the hospital frontlines to assist during the mounting workload as a result of the pandemic.

"There is very limited evidence and there are so many variables hence a proper study needed. Meanwhile, we propose that irrespective of ethnicity, senior and retired clinicians should be redeployed preferably away from frontline duties,” said Professor Parag Singhal, one of the doctors on the NHS frontlines.

"BAME doctors should discuss their underlying health issues with their employers to assess the risk," he said.

Indian-origin doctors, who make up a large chunk of the NHS workforce, are already among the victims of the deadly virus in the UK, including cardiac surgeon Wales-based Jitendra Kumar Rathod, 58, originally from Gujarat, and Birmingham-based Hamza Pacheeri, 80, from Kerala.

"Just as there is uncertainty about future predictions for the population, we don’t fully understand the Covid-19 related impact on the workforce, and their safety is paramount," notes BAPIO in its letter, a copy of which has also been sent to NHS England and Public Health England.

More For You

Camellia Panjabi's cookbook elevates
vegetables from sides to stars

Camellia Panjabi (Photo: Ursula Sierek)

Camellia Panjabi's cookbook elevates vegetables from sides to stars

RESTAURATEUR and writer Camellia Panjabi puts the spotlight on vegetables in her new book, as she said they were never given the status of a “hero” in the way fish, chicken or prawns are.

Panjabi’s Vegetables: The Indian Way features more than 120 recipes, with notes on nutrition, Ayurvedic insights and cooking methods that support digestion.

Keep ReadingShow less
Spotting the signs of dementia

Priya Mulji with her father

Spotting the signs of dementia

How noticing the changes in my father taught me the importance of early action, patience, and love

I don’t understand people who don’t talk or see their parents often. Unless they have done something to ruin your lives or you had a traumatic childhood, there is no reason you shouldn’t be checking in with them at least every few days if you don’t live with them.

Keep ReadingShow less
HH Guruji performed the Dhwaja Ritual at Ambaji Temple

HH Guruji performed the Dhwaja Ritual at Ambaji Temple

Mahesh Liloriya

The holy town of Ambaji witnessed a spiritually significant day on Sunday as His Holiness Siri Rajrajeshwar Guruji, head of the International Siddhashram Shakti Centre, London, performed the Dhwaja ritual at the historic Ambaji Temple in Gujarat, one of the most revered Shakti Peeths of India.

Keep ReadingShow less
Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Mahesh Liloriya

The International Siddhashram Shakti Centre in Harrow witnessed an inspiring and environmentally responsible celebration of Ganesh Utsav 2025, which concluded on Saturday, 6 September, with the Ganesh Visarjan ritual performed on the sacred occasion of Anant Chaturdashi.

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less